To explore the clinical relevance of DDX3X expression levels in patients with RCC, a cohort dataset comprising 525 clear-cell-type cases, including 57 matched adjacent normal and tumor cases from The Cancer Genome Atlas (TCGA), was analyzed. Here, DDX3X is linked to neoplasm.